Consultation on market access, reimbursement, marketing and sales to pharmaceutical and healthcare organizations:
• Developed market access launch strategy for Medicare Part B and Part D drugs
• Mentor and provide leadership on policy and regulations effecting sales, marketing and market access
• Provide leadership to cross functional teams to meet all organizational objectives
• Developed and executed pull through programs as a function of access versus market share

• Rare disease strategic reimbursement product launch plan input for a chemotherapy toxicity antidote within the oncology therapeutic area
• Strategic and tactical input for Specialty Pharmacy Patient (PAP) support program
• Developed and managed Pinnacle Health Group HUB for all specialty products
• Developed Centers for Medicare and Medicaid Services (CMS) strategy to obtain Hospital New Technology Add-On Payment (NTAP) and healthcare procedure codes.

Market Access strategy and tactical deployment for the Abilify (Buy & Bill) franchise, CNS therapeutic area and launch projects serving Account Executives, field sales and internal stakeholders:
• Developed, successfully deployed an innovative outreach pull through program that demonstrated 10:1 ROI
• Appointed to develop and execute an enterprise Market Access strategic process initiative
• Launch Contributor for value proposition development, cost & pricing ad boards for Rexulti®

• Managed Markets strategy development for Integrated Delivery Systems (IDNs), Accountable Care Organizations (ACOs), Group Purchasing Organizations (GPOs) and urology products and services
• Pull through strategy, tactics and ROI measurement across all segments
• Reimbursement, HUB services and specialty pharmacy channel experience
• Launch experience; Opana® (Pain), Fortesta Gel® (testosterone replacement), Valstar® (oncology Buy & Bill)